Cain, H., MacPherson, I.R. , Beresford, M., Pinder, S.E., Pong, J. and Dixon, J.M. (2017) Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clinical Oncology, 29(10), pp. 642-652. (doi: 10.1016/j.clon.2017.06.003) (PMID:28669449)
|
Text
143572.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 1MB |
Abstract
Neoadjuvant treatment offers a number of benefits for patients with early breast cancer, and is an important option for consideration by multidisciplinary teams. Despite literature showing its efficacy, the use of neoadjuvant therapy varies widely. Here we discuss the clinical evidence supporting the use of neoadjuvant therapy in early stage breast cancer, including patient selection, monitoring response, surgery and radiotherapy considerations, with the aim of assisting multidisciplinary teams to determine patient suitability for neoadjuvant treatment.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | MacPherson, Professor Iain |
Authors: | Cain, H., MacPherson, I.R., Beresford, M., Pinder, S.E., Pong, J., and Dixon, J.M. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | Clinical Oncology |
Publisher: | Elsevier |
ISSN: | 0936-6555 |
ISSN (Online): | 1433-2981 |
Published Online: | 29 June 2017 |
Copyright Holders: | Copyright © 2017 The Royal College of Radiologists |
First Published: | First published in Clinical Oncology 29(10): 642-652 |
Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record